Agendia(荷蘭)

Agendia

荷蘭Agendia www.agendia.comAgendia是開(kāi)發(fā)基于基因表達(dá)分析的診斷工具的全球領(lǐng)導(dǎo)企業(yè)。公司關(guān)注使用腫瘤基因表達(dá)分析的診斷化驗(yàn)工具的開(kāi)發(fā)與商業(yè)化。Agendia率先對(duì)于預(yù)后檢驗(yàn)——MammaPrint®——進(jìn)行了商業(yè)化，從而能夠預(yù)測(cè)乳腺癌重發(fā)的機(jī)率。Agendia的產(chǎn)品線最近又新增了發(fā)現(xiàn)未知癌瘤的CupPrin t®檢驗(yàn)。Agendia與荷蘭癌癥研究院(NKI)保持著密切聯(lián)系，從而能夠接觸到癌癥研究的發(fā)展。在開(kāi)發(fā)出了新型癌癥診斷技術(shù)之后，Agendia將會(huì)發(fā)揮它的專家技術(shù)，為那些關(guān)注治癌新藥開(kāi)發(fā)的企業(yè)尋找想要的新基因表達(dá)式。In2008,AgendialaunchesitsdiagnostictestTargetPrintforbreastcancerpatients,whichallowstoobtainhighlyreliablequantitativedataabouteachpatientsbreasttumorandaddsasecureprognostictoolforfuturetreatment.Leveragingthebenefitsofgeneexpressionprofiling-microarraytechnology–andcollaborationTheleadersofAgendiaaretheinventorsandinitiatorsofdiagnosticmicroarraytesting-thetechnologywhichformsthebasisforthecompany’scommerciallyavailabletests.Clinically-relevanttumorgeneexpressionprofilesareestablishedthroughin-houseresearch,